Improved Strategies for CRISPR-Cas12-based Nucleic Acids Detection

Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic : a systematic review. Ann Intern Med. 2021;174(5):655–62.

Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, Tambe M, Mina MJ, Parker R. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2021;7(1):eabd5393.

Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Feng Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020;505:172–5.

Wiedenheft B, Sternberg SH, Doudna JA. RNA-guided genetic silencing systems in bacteria and archaea. Nature. 2012;482(7385):331–8.

Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJ, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, van der Oost J, Backofen R, Koonin EV. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13(11):722–36.

Zetsche B, Gootenberg Jonathan S, Abudayyeh Omar O, Slaymaker Ian M, Makarova Kira S, Essletzbichler P, Volz Sara E, Joung J, van der Oost J, Regev A, Koonin Eugene V, Zhang F. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015;163(3):759–71.

Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436–9.

Li SY, Cheng QX, Liu JK, Nie XQ, Zhao GP, Wang J. CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res. 2018;28(4):491–3.

Singh D, Mallon J, Poddar A, Wang Y, Tippana R, Yang O, Bailey S, Ha T. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a). Proc Natl Acad Sci U S A. 2018;115(21):5444–9.

Wang SY, Du YC, Wang DX, Ma JY, Tang AN, Kong DM. Signal amplification and output of CRISPR/Cas-based biosensing systems: a review. Anal Chim Acta. 2021;1185: 338882.

Feng W, Newbigging AM, Tao J, Cao Y, Peng H, Le C, Wu J, Pang B, Li J, Tyrrell DL, Zhang H, Le XC. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules. Chem Sci. 2021;12(13):4683–98.

Fonfara I, Richter H, Bratovic M, Le Rhun A, Charpentier E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature. 2016;532(7600):517–21.

Ma P, Meng Q, Sun B, Zhao B, Dang L, Zhong M, Liu S, Xu H, Mei H, Liu J, Chi T, Yang G, Liu M, Huang X, Wang X. MeCas12a, a Highly Sensitive and Specific System for COVID-19 Detection. Adv Sci (Weinh). 2020:2001300.

Nguyen LT, Smith BM, Jain PK. Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection. Nat Commun. 2020;11(1):4906.

Yue H, Shu B, Tian T, Xiong E, Huang M, Zhu D, Sun J, Liu Q, Wang S, Li Y, Zhou X. Droplet Cas12a assay enables DNA quantification from unamplified samples at the single-molecule level. Nano Lett. 2021;21(11):4643–53.

Lv H, Wang J, Zhang J, Chen Y, Yin L, Jin D, Gu D, Zhao H, Xu Y, Wang J. Definition of CRISPR Cas12a trans-cleavage units to facilitate CRISPR diagnostics. Front Microbiol. 2021;12: 766464.

Li Z, Zhao W, Ma S, Li Z, Yao Y, Fei T. A chemical-enhanced system for CRISPR-based nucleic acid detection. Biosens Bioelectron. 2021;192: 113493.

Hsieh K, Zhao G, Wang TH. Applying biosensor development concepts to improve preamplification-free CRISPR/Cas12a-Dx. Analyst. 2020;145(14):4880–8.

Li L, Li S, Wu N, Wu J, Wang G, Zhao G, Wang J. HOLMESv2: a CRISPR-Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation. ACS Synth Biol. 2019;8(10):2228–37.

Bin Moon S, Lee JM, Kang JG, Lee NE, Ha DI, Kim DY, Kim SH, Yoo K, Kim D, Ko JH, Kim YS. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3’-overhang. Nat Commun. 2018;9(1):3651.

Park HM, Liu H, Wu J, Chong A, Mackley V, Fellmann C, Rao A, Jiang F, Chu H, Murthy N, Lee K. Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo. Nat Commun. 2018;9(1):3313.

Kim H, Lee WJ, Oh Y, Kang SH, Hur JK, Lee H, Song W, Lim KS, Park YH, Song BS, Jin YB, Jun BH, Jung C, Lee DS, Kim SU, Lee SH. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide. Nucleic Acids Res. 2020;48(15):8601–16.

Li B, Zhao W, Luo X, Zhang X, Li C, Zeng C, Dong Y. Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency. Nat Biomed Eng. 2017;1(5):0066.

McMahon MA, Prakash TP, Cleveland DW, Bennett CF, Rahdar M. Chemically modified Cpf1-CRISPR RNAs mediate efficient genome editing in Mammalian cells. Mol Ther Nucleic Acids. 2018;26(5):1228–40.

Ooi KH, Liu MM, Tay JWD, Teo SY, Kaewsapsak P, Jin S, Lee CK, Hou J, Maurer-Stroh S, Lin W, Yan B, Yan G, Gao YG, Tan MH. An engineered CRISPR-Cas12a variant and DNA–RNA hybrid guides enable robust and rapid COVID-19 testing. Nat Commun. 2021;12(1):1739.

Shi K, Xie S, Tian R, Wang S, Lu Q, Gao D, Lei C, Zhu H, Nie Z. A CRISPR-Cas autocatalysis-driven feedback amplification network for supersensitive DNA diagnostics. Sci Adv. 2021;7(5):eabc7802.

Wang B, Wang R, Wang D, Wu J, Li J, Wang J, Liu H, Wang Y. Cas12aVDet: a CRISPR/Cas12a-based platform for rapid and visual nucleic acid detection. Anal Chem. 2019;91(19):12156–61.

Wu H, He JS, Zhang F, Ping J, Wu J. Contamination-free visual detection of CaMV35S promoter amplicon using CRISPR/Cas12a coupled with a designed reaction vessel: rapid, specific and sensitive. Anal Chim Acta. 2020;1096:130–7.

Chen Y, Shi Y, Chen Y, Yang Z, Wu H, Zhou Z, Li J, Ping J, He L, Shen H, Chen Z, Wu J, Yu Y, Zhang Y, Chen H. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron. 2020;169: 112642.

Wu H, Chen Y, Yang Q, Peng C, Wang X, Zhang M, Qian S, Xu J, Wu J. A reversible valve-assisted chip coupling with integrated sample treatment and CRISPR/Cas12a for visual detection of Vibrio parahaemolyticus. Biosens Bioelectron. 2021;188: 113352.

Wu H, Qian C, Wu C, Wang Z, Wang D, Ye Z, Ping J, Wu J, Ji F. End-point dual specific detection of nucleic acids using CRISPR/Cas12a based portable biosensor. Biosens Bioelectron. 2020;157: 112153.

Wang R, Chen R, Qian C, Pang Y, Wu J, Li F. Ultrafast visual nucleic acid detection with CRISPR/Cas12a and rapid PCR in single capillary. Sens Actuator A Phys. 2021;326: 128618.

Yin K, Ding X, Li Z, Zhao H, Cooper K, Liu C. Dynamic aqueous multiphase reaction system for one-pot CRISPR-Cas12a-based ultrasensitive and quantitative molecular diagnosis. Anal Chem. 2020;92(12):8561–8.

Ding X, Yin K, Li Z, Lalla RV, Ballesteros E, Sfeir MM, Liu C. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020;11(1):4711.

Chen Y, Mei Y, Zhao X, Jiang X. Reagents-loaded, automated assay that integrates recombinase-aided amplification and Cas12a nucleic acid detection for a point-of-care test. Anal Chem. 2020;92(21):14846–52.

Joung J, Ladha A, Saito M, Kim NG, Woolley AE, Segel M, Barretto RPJ, Ranu A, Macrae RK, Faure G, Ioannidi EI, Krajeski RN, Bruneau R, Huang MLW, Yu XG, Li JZ, Walker BD, Hung DT, Greninger AL, Jerome KR, Gootenberg JS, Abudayyeh OO, Zhang F. Detection of SARS-CoV-2 with SHERLOCK one-pot testing. N Engl J Med. 2020;383(15):1492–4.

Ding X, Xu Z, Yin K, Sfeir M, Liu C. Dual-priming isothermal amplification (DAMP) for highly sensitive and specific molecular detection with ultralow nonspecific signals. Anal Chem. 2019;91(20):12852–8.

Ding X, Yin K, Li Z, Sfeir MM, Liu C. Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay. Biosens Bioelectron. 2021;184: 113218.

Feng W, Peng H, Xu J, Liu Y, Pabbaraju K, Tipples G, Joyce MA, Saffran HA, Tyrrell DL, Babiuk S, Zhang H, Le XC. Integrating reverse transcription recombinase polymerase amplification with CRISPR technology for the one-tube assay of RNA. Anal Chem. 2021;93(37):12808–16.

Lee RA, Puig H, Nguyen PQ, Angenent-Mari NM, Donghia NM, McGee JP, Dvorin JD, Klapperich CM, Pollock NR, Collins JJ. Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria. Proc Natl Acad Sci USA. 2020;117(41):25722–31.

de Puig H, Lee RA, Najjar D, Tan X, Soekensen LR, Angenent-Mari NM, Donghia NM, Weckman NE, Ory A, Ng CF, Nguyen PQ, Mao AS, Ferrante TC, Lansberry G, Sallum H, Niemi J, Collins JJ. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci Adv. 2021;7(32):eabh2944.

Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360(6387):439–44.

Yue H, Huang M, Tian T, Xiong E, Zhou X. Advances in clustered, regularly interspaced short palindromic repeats (CRISPR)-based diagnostic assays assisted by micro/nanotechnologies. ACS Nano. 2021;15(5):7848–59.

Huang X, Aguilar ZP, Xu H, Lai W, Xiong Y. Membrane-based lateral flow immunochromatographic strip with nanoparticles as reporters for detection: a review. Biosens Bioelectron. 2016;75:166–80.

Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A, Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu CY. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020;38(7):870–4.

Bai J, Lin H, Li H, Zhou Y, Liu J, Zhong G, Wu L, Jiang W, Du H, Yang J, Xie Q, Huang L. Cas12a-based on-site and rapid nucleic acid detection of african swine fever. Front Microbiol. 2019;10:2830.

Yuan T, Mukama O, Li Z, Chen W, Zhang Y, de Dieu HJ, Zhang Y, Zeng R, Nie C, He Z, Zeng L. A rapid and sensitive CRISPR/Cas12a based lateral flow biosensor for the detection of Epstein-Barr virus. Analyst. 2020;145(19):6388–94.

Mukama O, Wu J, Li Z, Liang Q, Yi Z, Lu X, Liu Y, Liu Y, Hussain M, Makafe GG, Liu J, Xu N, Zeng L. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids. Biosens Bioelectron. 2020;159: 112143.

Yuan C, Tian T, Sun J, Hu M, Wang X, Xiong E, Cheng M, Bao Y, Lin W, Jiang J, Yang C, Chen Q, Zhang H, Wang H, Wang X, Deng X, Liao X, Liu Y, Wang Z, Zhang G, Zhou X. Universal and naked-eye gene detection platform based on the clustered regularly interspaced short palindromic repeats/Cas12a/13a system. Anal Chem. 2020;92(5):4029–37.

Li Y, Mansour H, Wang T, Poojari S, Li F. Naked-eye detection of grapevine red-blotch viral infection using a plasmonic CRISPR Cas12a assay. Anal Chem. 2019;91(18):11510–3.

Jiang Y, Hu M, Liu AA, Lin Y, Liu L, Yu B, Zhou X, Pang DW. Detection of SARS-CoV-2 by CRISPR/Cas12a-enhanced colorimetry. ACS Sens. 2021;6(3):1086–93.

Hu M, Yuan C, Tian T, Wang X, Sun J, Xiong E, Zhou X. Single-step, salt-aging-free, and thiol-free freezing construction of AuNP-based bioprobes for advancing CRISPR-based diagnostics. J Am Chem Soc. 2020;142(16):7506–13.

Zhang WS, Pan J, Li F, Zhu M, Xu M, Zhu H, Yu Y, Su G. Reverse transcription recombinase polymerase amplification coupled with CRISPR-Cas12a for facile and highly sensitive colorimetric SARS-CoV-2 detection. Anal Chem. 2021;93(8):4126–33.

Shao N, Han X, Song Y, Zhang P, Qin L. CRISPR-Cas12a coupled with platinum nanoreporter for visual quantification of SNVs on a volumetric bar-chart chip. Anal Chem. 2019;91(19):12384–91.

Park JS, Hsieh K, Chen L, Kaushik A, Trick AY, Wang TH. Digital CRISPR/Cas-assisted assay for rapid and sensitive detection of SARS-CoV-2. Adv Sci (Weinh). 2021;8(5):2003564.

Wu X, Tay JK, Goh CK, Chan C, Lee YH, Springs SL, Wang Y, Loh KS, Lu TK, Yu H. Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acids. Biomaterials. 2021;274: 120876.

Yu T, Zhang S, Matei R, Marx W, Beisel CL, Wei Q. Coupling smartphone and CRISPR–Cas12a for digital and multiplexed nucleic acid detection. AIChE J. 2021;12: e17365.

Shebanova R, Nikitchina N, Shebanov N, Mekler V, Kuznedelov K, Ulashchik E, Vasilev R, Sharko O, Shmanai V, Tarassov I, Severinov K, Entelis N, Mazunin I. Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA. Nucleic Acids Res. 2022;50(2):1162–73.